987 studies found for:    "Carcinoma, Hepatocellular"
Show Display Options
RSS Create an RSS feed from your search for:
"Carcinoma, Hepatocellular"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Hepatoma
Intervention: Device: SIR-Spheres microspheres
2 Terminated Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma Non-resectable;   Hepatocellular Carcinoma Recurrent;   Carcinoma, Hepatocellular;   Liver Diseases;   Neoplasms by Histologic Type;   Digestive System Neoplasms;   Carcinoma;   Liver Neoplasms;   Neoplasms;   Neoplasms by Site;   Digestive System Diseases;   Adenocarcinoma;   Neoplasms, Glandular and Epithelial
Interventions: Drug: ABT-869;   Drug: Sorafenib
3 Terminated
Has Results
Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Hepatobiliary Neoplasm;   Liver Carcinoma
Interventions: Procedure: TACE;   Procedure: SBRT
4 Completed Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis
Conditions: Carcinoma, Hepatocellular;   Hepatitis, Viral, Human
Intervention: Drug: 131 I-lipiodol
5 Unknown  Proteomic Analysis of Human Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: Operation
6 Recruiting SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE
Condition: Carcinoma, Hepatocellular
Intervention: Radiation: SBRT
7 Completed PI-88 in Hepatocellular Carcinoma After Hepatectomy
Condition: Carcinoma, Hepatocellular
Intervention: Drug: PI-88
8 Recruiting A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
Conditions: Liver Tumors;   Hepatocellular Carcinoma;   Hepatoma;   Neoplasms
Intervention: Device: TheraSphere®
9 Unknown  Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: epirubicin;   Drug: Cisplatin
10 Unknown  Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: percutaneous ethanol instillation (PEI)
11 Unknown  Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma
Conditions: Hepatitis B;   Carcinoma, Hepatocellular;   Polymorphism, Genetic
Intervention:
12 Terminated Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: percutaneous ablation of hepatocellular carcinoma
13 Recruiting Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Procedure: Transarterial Chemoembolization;   Radiation: Proton Beam Radiotherapy
14 Completed A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.
Condition: Carcinoma, Hepatocellular
Intervention: Biological: GV1001
15 Enrolling by invitation Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Device: Arsenic trioxide TACE;   Drug: Arsenic trioxide intravenous infusion;   Drug: lipiodol;   Drug: NaCl solution
16 Recruiting Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Radiation: IGRT;   Drug: Capecitabine;   Drug: Oxaliplatin
17 Recruiting Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco Criteria
Condition: Carcinoma, Hepatocellular
Interventions: Radiation: Proton Beam Radiotherapy;   Drug: Sorafenib
18 Recruiting Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Subjects With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: MSC2156119J;   Drug: Sorafenib
19 Terminated Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma
Conditions: Cancer;   Liver Cancer;   Primary Liver Cancer;   Hepatocellular Carcinoma;   Hepatoma
Interventions: Drug: PI-88;   Drug: placebo
20 Not yet recruiting Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Participants With Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Part 1: JNJ-42756493;   Drug: Part 2: JNJ-42756493

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years